查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球 COVID-19 诊断市场——行业分析、规模、份额、增长、趋势、预测，2022-2031 年
市场调查报告书
商品编码
1229587

全球 COVID-19 诊断市场——行业分析、规模、份额、增长、趋势、预测，2022-2031 年

COVID-19 Diagnostics Market (Product: Instruments and Reagents & Kits; Test Type: Molecular Tests, Antigen Tests, and Antibody Tests) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
出版日期: | 出版商: Transparency Market Research | 英文 226 Pages | 商品交期: 2-10个工作天内

价格

本报告介绍了 2017 年至 2031 年全球 COVID-19 诊断市场的收入，基准年为 2022 年，预测年为 2031 年。它还介绍了 2022 年至 2031 年全球 COVID-19 诊断市场的复合年增长率 (CAGR %)。

本报告是广泛研究的结果。在初步研究中，分析师对主要思想领袖、行业领袖和舆论製造者进行访谈，他们提供了大量的研究工作。在二次调研中，我们参考了各大公司的产品资料、年报、新闻稿、相关文件等，瞭解COVID-19诊断市场。

该报告深入探讨了全球 COVID-19 诊断市场的竞争格局。已经确定了在全球 COVID-19 诊断市场上运营的主要参与者，并根据各种属性对每家公司进行了介绍。公司概况、财务状况、近期发展和 SWOT 是本报告中描述的全球 COVID-19 诊断市场参与者的属性。

目录

第一章 前言

  • 市场定义和范围
  • 市场细分
  • 主要研究目的
  • 调查亮点

第二章前提条件和研究方法

第 3 章执行摘要：全球 COVID-19 诊断市场

第四章市场概况

  • 介绍
    • 段定义
    • 行业的演变与发展
  • 概述
  • 市场动态
    • 促进者
    • 抑製剂
    • 机会
  • 2020-2031 年 COVID-19 诊断全球市场分析与预测

第 5 章关键见解

  • 技术进步
  • COVID-19抗原诊断测试管道
  • 关于 FDA 批准的家庭诊断 "COVID-19" 的思考
  • 各国对 COVID-19 诊断的监管批准

第 6 章 COVID-19 诊断的全球市场分析和预测：按产品分类

  • 介绍和定义
  • 重大发现/发展
  • 市场价值预测：按产品分类，2020-2031 年
    • 机器
    • 试剂/试剂盒
  • 市场吸引力分析：按产品

第 7 章 COVID-19 诊断的全球市场分析和预测：按测试类型

  • 介绍和定义
  • 重大发现/发展
  • 市场价值预测：按测试类型，2020-2031 年
    • 分子生物学测试
    • 抗原检测
    • 抗体（血清学）测试
  • 市场吸引力分析：按测试类型

第 8 章 COVID-19 诊断的全球市场分析和预测：最终用户

  • 介绍和定义
  • 重大发现/发展
  • 市场价值预测：按最终用户分类，2020-2031 年
    • 医院/诊所
    • 在家测试
    • 其他
  • 市场吸引力分析：按最终用户

第 9 章 COVID-19 诊断的全球市场分析和预测：按地区

  • 主要发现
  • 市场价值预测：按地区划分，2020-2031 年
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东/非洲
  • 市场吸引力分析：按地区

第 10 章北美 COVID-19 诊断市场分析与预测

  • 介绍
    • 主要发现
  • 市场价值预测：按产品分类，2020-2031 年
    • 机器
    • 试剂/试剂盒
  • 市场价值预测：按测试类型，2020-2031 年
    • 分子生物学测试
    • 抗原检测
    • 抗体（血清学）测试
  • 市场价值预测：按最终用户分类，2020-2031 年
    • 医院/诊所
    • 在家测试
    • 其他
  • 2020-2031 年各国市场价值预测
    • 美国
    • 加拿大
  • 市场吸引力分析
    • 按产品
    • 按测试类型
    • 按最终用户
    • 按国家

第 11 章欧洲 COVID-19 诊断市场分析与预测

  • 介绍
    • 主要发现
  • 市场价值预测：按产品分类，2020-2031 年
    • 机器
    • 试剂/试剂盒
  • 市场价值预测：按测试类型，2020-2031 年
    • 分子生物学测试
    • 抗原检测
    • 抗体（血清学）测试
  • 市场价值预测：按最终用户分类，2020-2031 年
    • 医院/诊所
    • 在家测试
    • 其他
  • 市场价值预测：按国家/地区分类，2020-2031 年
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 欧洲其他地区
  • 市场吸引力分析
    • 按产品
    • 按测试类型
    • 按最终用户
    • 按国家/地区

第 12 章亚太 COVID-19 诊断市场分析与预测

  • 介绍
    • 主要发现
  • 市场价值预测：按产品分类，2020-2031 年
    • 机器
    • 试剂/试剂盒
  • 市场价值预测：按测试类型，2020-2031 年
    • 分子生物学测试
    • 抗原检测
    • 抗体（血清）检测
  • 市场价值预测：按最终用户分类，2020-2031 年
    • 医院/诊所
    • 在家测试
    • 其他
  • 市场价值预测：按国家/地区分类，2020-2031 年
    • 中国
    • 日本
    • 印度
    • 澳大利亚/新西兰
    • 亚太其他地区
  • 市场吸引力分析
    • 按产品
    • 按测试类型
    • 按最终用户
    • 按国家/地区

第 13 章拉丁美洲 COVID-19 诊断市场分析与预测

  • 介绍
    • 主要发现
  • 市场价值预测：按产品分类，2020-2031 年
    • 机器
    • 试剂/试剂盒
  • 市场价值预测：按测试类型，2020-2031 年
    • 分子生物学测试
    • 抗原检测
    • 抗体（血清学）测试
  • 市场价值预测：按最终用户分类，2020-2031 年
    • 医院/诊所
    • 在家测试
    • 其他
  • 市场价值预测：按国家/地区分类，2020-2031 年
    • 巴西
    • 墨西哥
    • 其他拉丁美洲地区
  • 市场吸引力分析
    • 按产品
    • 按测试类型
    • 按最终用户
    • 按国家/地区

第 14 章中东和非洲 COVID-19 诊断市场分析与预测

  • 介绍
    • 主要发现
  • 市场价值预测：按产品分类，2020-2031 年
    • 机器
    • 试剂/试剂盒
  • 市场价值预测：按测试类型，2020-2031 年
    • 分子生物学测试
    • 抗原检测
    • 抗体（血清学）测试
  • 市场价值预测：按最终用户分类，2020-2031 年
    • 医院/诊所
    • 在家测试
    • 其他
  • 市场价值预测：按国家/地区分类，2020-2031 年
    • 海湾合作委员会国家
    • 南非
    • 中东和非洲其他地区
  • 市场吸引力分析
    • 按产品
    • 按测试类型
    • 按最终用户
    • 按国家/地区

第十五章竞争格局

  • 市场参与者 - 竞争矩阵（按公司级别、公司规模）
  • 市场份额分析：按公司分类，2021 年
  • 公司简介
    • Abbott Laboratories
    • Becton, Dickinson and Company（BD）
    • Bio-Rad Laboratories, Inc.
    • Danaher Corporation（Cepheid）
    • F. Hoffmann-La Roche Ltd.（Roche Diagnostics）
    • Hologic, Inc.
    • Laboratory Corporation of America Holdings
    • PerkinElmer, Inc.
    • Quest Diagnostics
    • Thermo Fisher Scientific, Inc.
Product Code: TMRGL80305

The report provides revenue of the global COVID-19 diagnostics market for the period 2017-2031, considering 2022 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global COVID-19 diagnostics market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the COVID-19 diagnostics market.

The report delves into the competitive landscape of the global COVID-19 diagnostics market. Key players operating in the global COVID-19 diagnostics market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global COVID-19 diagnostics market profiled in this report.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global COVID-19 Diagnostics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global COVID-19 Diagnostics Market Analysis and Forecast, 2020-2031

5. Key Insights

  • 5.1. Technological Advancements
  • 5.2. COVID-19 Antigen Diagnostic Test Pipeline
  • 5.3. Insights on FDA Approved COVID-19 Home Diagnostic Test
  • 5.4. Regulatory Authorizations by Country for COVID-19 Diagnostic Tests

6. Global COVID-19 Diagnostics Market Analysis and Forecast, by Product

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product, 2020-2031
    • 6.3.1. Instruments
    • 6.3.2. Reagents & Kits
  • 6.4. Market Attractiveness Analysis, by Product

7. Global COVID-19 Diagnostics Market Analysis and Forecast, by Test Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Test Type, 2020-2031
    • 7.3.1. Molecular Tests
    • 7.3.2. Antigen Test
    • 7.3.3. Antibody (serology) Tests
  • 7.4. Market Attractiveness Analysis, by Test Type

8. Global COVID-19 Diagnostics Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by End-user, 2020-2031
    • 8.3.1. Hospitals & Clinics
    • 8.3.2. At-home Testing
    • 8.3.3. Others
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global COVID-19 Diagnostics Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2020-2031
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America COVID-19 Diagnostics Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product, 2020-2031
    • 10.2.1. Instruments
    • 10.2.2. Reagents & Kits
  • 10.3. Market Value Forecast, by Test Type, 2020-2031
    • 10.3.1. Molecular Tests
    • 10.3.2. Antigen Test
    • 10.3.3. Antibody (serology) Tests
  • 10.4. Market Value Forecast, by End-user, 2020-2031
    • 10.4.1. Hospitals & Clinics
    • 10.4.2. At-home Testing
    • 10.4.3. Others
  • 10.5. Market Value Forecast, by Country, 2020-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Product
    • 10.6.2. By Test Type
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe COVID-19 Diagnostics Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product, 2020-2031
    • 11.2.1. Instruments
    • 11.2.2. Reagents & Kits
  • 11.3. Market Value Forecast, by Test Type, 2020-2031
    • 11.3.1. Molecular Tests
    • 11.3.2. Antigen Test
    • 11.3.3. Antibody (serology) Tests
  • 11.4. Market Value Forecast, by End-user, 2020-2031
    • 11.4.1. Hospitals & Clinics
    • 11.4.2. At-home Testing
    • 11.4.3. Others
  • 11.5. Market Value Forecast, by Country/Sub-region, 2020-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Product
    • 11.6.2. By Test Type
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific COVID-19 Diagnostics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product, 2020-2031
    • 12.2.1. Instruments
    • 12.2.2. Reagents & Kits
  • 12.3. Market Value Forecast, by Test Type, 2020-2031
    • 12.3.1. Molecular Tests
    • 12.3.2. Antigen Test
    • 12.3.3. Antibody (Serology) Tests
  • 12.4. Market Value Forecast, by End-user, 2020-2031
    • 12.4.1. Hospitals & Clinics
    • 12.4.2. At-home Testing
    • 12.4.3. Others
  • 12.5. Market Value Forecast, by Country/Sub-region, 2020-2031
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Product
    • 12.6.2. By Test Type
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America COVID-19 Diagnostics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product, 2020-2031
    • 13.2.1. Instruments
    • 13.2.2. Reagents & Kits
  • 13.3. Market Value Forecast, by Test Type, 2020-2031
    • 13.3.1. Molecular Tests
    • 13.3.2. Antigen Test
    • 13.3.3. Antibody (serology) Tests
  • 13.4. Market Value Forecast, by End-user, 2020-2031
    • 13.4.1. Hospitals & Clinics
    • 13.4.2. At-home Testing
    • 13.4.3. Others
  • 13.5. Market Value Forecast, by Country/Sub-region, 2020-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Product
    • 13.6.2. By Test Type
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa COVID-19 Diagnostics Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product, 2020-2031
    • 14.2.1. Instruments
    • 14.2.2. Reagents & Kits
  • 14.3. Market Value Forecast, by Test Type, 2020-2031
    • 14.3.1. Molecular Tests
    • 14.3.2. Antigen Test
    • 14.3.3. Antibody (serology) Tests
  • 14.4. Market Value Forecast, by End-user, 2020-2031
    • 14.4.1. Hospitals & Clinics
    • 14.4.2. At-home Testing
    • 14.4.3. Others
  • 14.5. Market Value Forecast, by Country/Sub-region, 2020-2031
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of MEA
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Product
    • 14.6.2. By Test Type
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competitive Matrix (by tier and size of companies)
  • 15.2. Market Share Analysis, by Company, 2021
  • 15.3. Company Profiles
    • 15.3.1. Abbott Laboratories
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. SWOT Analysis
      • 15.3.1.4. Financial Overview
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Becton, Dickinson and Company (BD)
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. SWOT Analysis
      • 15.3.2.4. Financial Overview
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Bio-Rad Laboratories, Inc.
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. SWOT Analysis
      • 15.3.3.4. Financial Overview
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Danaher Corporation (Cepheid)
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. SWOT Analysis
      • 15.3.4.4. Financial Overview
      • 15.3.4.5. Strategic Overview
    • 15.3.5. F. Hoffmann-La Roche Ltd. (Roche Diagnostics)
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. SWOT Analysis
      • 15.3.5.4. Financial Overview
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Hologic, Inc.
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. SWOT Analysis
      • 15.3.6.4. Financial Overview
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Laboratory Corporation of America Holdings
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. SWOT Analysis
      • 15.3.7.4. Financial Overview
      • 15.3.7.5. Strategic Overview
    • 15.3.8. PerkinElmer, Inc.
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. SWOT Analysis
      • 15.3.8.4. Financial Overview
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Quest Diagnostics
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. SWOT Analysis
      • 15.3.9.4. Financial Overview
      • 15.3.9.5. Strategic Overview
    • 15.3.10. Thermo Fisher Scientific, Inc.
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. SWOT Analysis
      • 15.3.10.4. Financial Overview
      • 15.3.10.5. Strategic Overview

List of Tables

  • Table 01: Global COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Product, 2020-2031
  • Table 02: Global COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2020-2031
  • Table 03: Global COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2020-2031
  • Table 04: Global COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Region, 2020-2031
  • Table 05: North America COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Country, 2020-2031
  • Table 06: North America COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Product, 2020-2031
  • Table 07: North America COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2020-2031
  • Table 08: North America COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2020-2031
  • Table 09: Europe COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2031
  • Table 10: Europe COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Product, 2020-2031
  • Table 11: Europe COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2020-2031
  • Table 12: Europe COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2020-2031
  • Table 13: Asia Pacific COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2031
  • Table 14: Asia Pacific COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Product, 2020-2031
  • Table 15: Asia Pacific COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2020-2031
  • Table 16: Asia Pacific COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2020-2031
  • Table 17: Latin America COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2031
  • Table 18: Latin America COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Product, 2020-2031
  • Table 19: Latin America COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2020-2031
  • Table 20: Latin America COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2020-2031
  • Table 21: Middle East & Africa COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2031
  • Table 22: Middle East & Africa COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Product, 2020-2031
  • Table 23: Middle East & Africa COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2020-2031
  • Table 24: Middle East & Africa COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2020-2031

List of Figures

  • Figure 01: Global COVID-19 Diagnostics Market Size (US$ Mn) and Distribution (%), by Region, 2021 and 2031
  • Figure 02: Global COVID-19 Diagnostics Market Revenue (US$ Mn), by Product, 2021
  • Figure 03: Global COVID-19 Diagnostics Market Value Share, by Product, 2021
  • Figure 04: Global COVID-19 Diagnostics Market Revenue (US$ Mn), by Test Type, 2021
  • Figure 05: Global COVID-19 Diagnostics Market Value Share, by Test Type, 2021
  • Figure 06: Global COVID-19 Diagnostics Market Revenue (US$ Mn), by End-user, 2021
  • Figure 07: Global COVID-19 Diagnostics Market Value Share, by End-user, 2021
  • Figure 08: Global COVID-19 Diagnostics Market Value Share, by Region, 2021
  • Figure 09: Global COVID-19 Diagnostics Market Value (US$ Mn) Forecast, 2020-2031
  • Figure 10: Global COVID-19 Diagnostics Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 11: Global COVID-19 Diagnostics Market Attractiveness Analysis, by Product, 2022-2031
  • Figure 12: Global COVID-19 Diagnostics Market Value Share Analysis, by Test Type, 2021 and 2031
  • Figure 13: Global COVID-19 Diagnostics Market Attractiveness Analysis, by Test Type, 2022-2031
  • Figure 14: Global COVID-19 Diagnostics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 15: Global COVID-19 Diagnostics Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 16: Global COVID-19 Diagnostics Market Value Share Analysis, by Region, 2021 and 2031
  • Figure 17: Global COVID-19 Diagnostics Market Attractiveness Analysis, by Region, 2022-2031
  • Figure 18: North America COVID-19 Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2031
  • Figure 19: North America COVID-19 Diagnostics Market Attractiveness Analysis, by Country, 2020-2031
  • Figure 20: North America COVID-19 Diagnostics Market Value Share Analysis, by Country, 2021 and 2031
  • Figure 21: North America COVID-19 Diagnostics Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 22: North America COVID-19 Diagnostics Market Value Share Analysis, by Test Type, 2021 and 2031
  • Figure 23: North America COVID-19 Diagnostics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 24: North America COVID-19 Diagnostics Market Attractiveness Analysis, by Product, 2022-2031
  • Figure 25: North America COVID-19 Diagnostics Market Attractiveness Analysis, by Test Type, 2022-2031
  • Figure 26:North America COVID-19 Diagnostics Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 27: Europe COVID-19 Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2031
  • Figure 28: Europe COVID-19 Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2020-2031
  • Figure 29: Europe COVID-19 Diagnostics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 30: Europe COVID-19 Diagnostics Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 31: Europe COVID-19 Diagnostics Market Value Share Analysis, by Test Type, 2021 and 2031
  • Figure 32: Europe COVID-19 Diagnostics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 33: Europe COVID-19 Diagnostics Market Attractiveness Analysis, by Product, 2022-2031
  • Figure 34: Europe COVID-19 Diagnostics Market Attractiveness Analysis, by Test Type, 2022-2031
  • Figure 35: Europe COVID-19 Diagnostics Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 36: Asia Pacific COVID-19 Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2031
  • Figure 37: Asia Pacific COVID-19 Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2020-2031
  • Figure 38: Asia Pacific COVID-19 Diagnostics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 39: Asia Pacific COVID-19 Diagnostics Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 40: Asia Pacific COVID-19 Diagnostics Market Value Share Analysis, by Test Type, 2021 and 2031
  • Figure 41: Asia Pacific COVID-19 Diagnostics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 42: Asia Pacific COVID-19 Diagnostics Market Attractiveness Analysis, by Product, 2022-2031
  • Figure 43: Asia Pacific COVID-19 Diagnostics Market Attractiveness Analysis, by Test Type, 2022-2031
  • Figure 44: Asia Pacific COVID-19 Diagnostics Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 45: Latin America COVID-19 Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2031
  • Figure 46: Latin America COVID-19 Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2020-2031
  • Figure 47: Latin America COVID-19 Diagnostics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 48: Latin America COVID-19 Diagnostics Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 49: Latin America COVID-19 Diagnostics Market Value Share Analysis, by Test Type, 2021 and 2031
  • Figure 50: Latin America COVID-19 Diagnostics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 51: Latin America COVID-19 Diagnostics Market Attractiveness Analysis, by Product, 2022-2031
  • Figure 52: Latin America COVID-19 Diagnostics Market Attractiveness Analysis, by Test Type, 2022-2031
  • Figure 53: Latin America COVID-19 Diagnostics Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 54: Middle East & Africa COVID-19 Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2031
  • Figure 55: Middle East & Africa COVID-19 Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2020-2031
  • Figure 56: Middle East & Africa COVID-19 Diagnostics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 57: Middle East & Africa COVID-19 Diagnostics Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 58: Middle East & Africa COVID-19 Diagnostics Market Value Share Analysis, by Test Type, 2021 and 2031
  • Figure 59: Middle East & Africa COVID-19 Diagnostics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 60: Middle East & Africa COVID-19 Diagnostics Market Attractiveness Analysis, by Product, 2022-2031
  • Figure 61: Middle East & Africa COVID-19 Diagnostics Market Attractiveness Analysis, by Test Type, 2022-2031
  • Figure 62: Middle East & Africa COVID-19 Diagnostics Market Attractiveness Analysis, by End-user, 2022-2031